Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-06-05
2007-06-05
Ewoldt, G. R. (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S324000, C530S862000, C530S868000, C424S185100
Reexamination Certificate
active
11086903
ABSTRACT:
The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
REFERENCES:
patent: 4962035 (1990-10-01), Leder et al.
patent: 5770396 (1998-06-01), Kinet
patent: 5945294 (1999-08-01), Frank et al.
patent: 51113443 (1973-05-01), None
patent: WO 89/05352 (1989-06-01), None
patent: WO 90/04640 (1990-05-01), None
patent: WO 91/06570 (1991-05-01), None
patent: WO 93/04173 (1993-03-01), None
Abbas et al., Cellular and Molecular Immunology, fourth edition, W.B. Saunders Company, 2000, pp. 56-58.
Janeway et al, Immunobiology, third edition, garland Publishing Inc., 1997, p. 2:2.
McAleese et al. “Cloning and sequencing of the horse and sheep high-affinity IgE receptor alpha chain cDNA” Immunogenetics, 2000, 51:878-881.
Garman et al. “The crystal structure of the human high-affinity IgE receptor (FcepsilonRlalpha)” Annu. Rev. Immunol. 1999, 17:973-976.
Bhattacharya, et al., 1994,Cancer Immunol Immunother, vol. 38, pp. 75-82.
Blank, et al., 1991,The Journal of Biological Chemistry, vol. 266, No. 4, pp. 2639-2646.
Cunningham, et al., 1988,Science, vol. 2uu, pp. 1081-1085.
Hakimi, et al., 1990,The Journal of Biological Chemistry, vol. 265, No. 36, pp. 22079-22081.
Hayashi, et al., Genbank Accession No. D16413, submitted Jun. 8, 1993.
Kochan, et al., 1988,Nucleic Acids Res. 16(8), p. 3584.
Küster, et al., 1990,J. Biol. Chem. 265(11), pp. 6448-6452.
Küster, et al., 1992,J. Biol. Chem. 267(18), pp. 12782-12787.
Lowenthal, et al., 1993,Annals of Allergy 71, pp. 481-484.
Pang, et al., 1993,J. Immunol. 151(11), pp. 6166-6174.
Ra, et al., 1989Journal of Biological Chemistryvol. 264(26), pp. 15323-15327.
Ravetch, et al., 1991,Annu. Rev. Immunol. (9), pp. 457-492.
Rigby, et al., 2000,The Journal of Biological Chemistry, vol. 275, No. 13, pp. 9664-9672.
Robertson, Michael W., 1993,The Journal of Biological Chemistry, vol. 268, No. 17, pp. 12736-12743.
Shimizu, et al., 1988,Proc. Natl. Acad. Sci. USA(85), pp. 1907-1911.
McCall Catherine A.
Weber Eric R.
Ewoldt G. R.
Heska Corporation
Szperka Michael
LandOfFree
Equine Fc epsilon receptor alpha protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Equine Fc epsilon receptor alpha protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Equine Fc epsilon receptor alpha protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3848156